Version history

{
  "session_id": "sess_SDA-2026-04-12-gap-debate-20260410-113021-6fbc6da4_20260412-205720",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Mechanistically-Specific Hypotheses: SCFAs and α-Synuclein Aggregation\n\n---\n\n## Hypothesis 1: SCFA-Mediated TFEB Nuclear Translocation via Class I HDAC Inhibition Drives Autophagic α-Synuclein Clearance\n\n**Mechanism**: Butyrate (particularly at 1-2 mM colonic concentrations) inhibits class I HDACs (HDAC1/2/3) in neurons, relieving HDAC6-mediated repression of TFEB (Transcription Factor EB) transcriptional activity. TFEB activation upregulates a suite of lysosomal biogenesis genes including *LAMP1*, *LAMP2*, *CTSD* (cathepsin D), and *ATP6V1H*, enhancing autophagosome-lysosome fusion and selective autophagy of ubiquitinated protein aggregates. This mechanism is distinct from the previously hypothesized HDAC6 catalytic inhibition pathway.\n\n**Key Evidence**: Class I HDAC inhibitors (MS-275, valproic acid) induce TFEB nuclear translocation in neurons (PMID: 28178236). Butyrate administration in MPTP Parkinson's models reduces α-synuclein accumulation via autophagy upregulation (PMID: 30642069).\n\n**Testable Prediction**: Neuronal TFEB knockdown (siRNA or viral Cre-lox) in butyrate-treated α-synuclein PFF mouse models will completely abrogate SCFA-mediated reduction in Sarkozy-positive aggregates in substantia nigra, confirming TFEB as the obligatory intermediate.\n\n**Primary Target**: **TFEB** (transcriptional regulator)\n\n---\n\n## Hypothesis 2: GPR41-Specific Signaling Suppresses PERK/eIF2α Axis to Reduce ER Stress-Driven α-Synuclein Oligomerization\n\n**Mechanism**: Propionate (C3) preferentially activates GPR41 (FFAR3) over GPR43, engaging Gβγ-PLCβ3-Ca²⁺ signaling that selectively activates calcineurin. Calcineurin dephosphorylates ATF4 at Ser-251, attenuating PERK/eIF2α-dependent translational repression while paradoxically sustaining ATF4's transcription of antioxidant and ER chaperone genes (*BiP/HSPA5*, *XBP1s*, *CHOP*). Reduced eIF2α phosphorylation restores global translation while elevated ER chaperones prevent misfolded α-synuclein from entering toxic oligomeric pathways. This model dissociates the ER stress response into adaptive (ATF4 survival signaling) and maladaptive (PERK translation attenuation) branches.\n\n**Key Evidence**: GPR41 deletion in mice exacerbates ER stress in metabolic tissues (PMID: 21270256). Propionate supplementation reduces PERK activation in hepatic steatosis models (PMID: 31781376).\n\n**Testable Prediction**: GPR41⁻/⁻ mice crossed with α-synuclein A53T transgenic mice will show accelerated oligomer accumulation and earlier motor deficits compared to vehicle-treated controls, with no rescue by propionate supplementation—falsifying if GPR41 signaling is the critical node.\n\n**Primary Target**: **GPR41/FFAR3** (receptor), **ATF4** (transcription factor)\n\n---\n\n## Hypothesis 3: SCFA-Derived Acetyl-CoA Pools Rewire Histone Crotonylation at Hsp70 Promoter to Enhance Chaperone-Mediated Aggregate Disassembly\n\n**Mechanism**: Butyrate catabolism via acetyl-CoA synthetase (ACSS1 in mitochondria) generates acetyl-CoA pools that serve as substrates for both histone acetyltransferases (HATs) and histone crotonyltransferases (HATs with crotonyl-CoA specificity, e.g., p300/CBP). Elevated histone crotonylation (Kcr) at the *HSP70",
  "tokens_used": "799"
}